TCL Archive Bad News for EPO Products Brings FDA Scrutiny, Payment Curbs. FDA Issues Alert to Doctors. February 23, 2007
TCL Archive Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.” December 16, 2005
TCL Archive ABMT Trials Unlikely To show Clean Benefit for Breast Cancer; Data Release Debated March 12, 1999